BD (NYSE: BDX) shares took a hit today on second-quarter results that were mixed compared to the consensus forecast..

Spark Biomedical announced today that it closed a $15 million Series A round to support its bioelectronic neurostimulation ...

Ivan Tornos shares a "98% accurate" tale of how he got Arnold Schwarzenegger pumped up to be Zimmer Biomet's celebrity ...

Surmodics is "working diligently" in response to the FTC’s lawsuit seeking to block its $627 million sale to GTCR, CEO Gary ...

GE HealthCare Q1 results beat the Wall Street analyst consensus — but it lowered its full-year EPS guidance due to tariff ...

Coramaze Technologies announced that it appointed former Medtronic executive Rob ten Hoedt as the chair of its board of ...

Transverse Medical announced that it completed its Series B2 financing round worth more than $10 million in new capital.